Wolfe Research Upgrades Alnylam Pharmaceuticals (ALNY) to Peerperform

August 4, 2025 6:01 AM EDT Send to a Friend
(Updated - August 4, 2025 6:11 AM EDT)

Wolfe Research analyst Andy Chen upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login